Distinctive multicellular immunosuppressive hubs confer different intervention strategies for left- and right-sided colon cancers

Bingxin Liu,Shuwei Li,Yifei Cheng,Peng Song,Menghuan Xu,Zhengyi Li,Wei Shao,Junyi Xin,Zan Fu,Dongying Gu,Mulong Du,Zhengdong Zhang,Meilin Wang
DOI: https://doi.org/10.1016/j.xcrm.2024.101589
2024-06-18
Abstract:Primary colon cancers arising from the left and right sides exhibit distinct clinical and molecular characteristics. Sidedness-associated heterogeneity relies intricately on the oncogenic properties of cancer cells and multicellular interactions in tumor microenvironments. Here, combining transcriptomic profiling of 426,863 single cells from 105 colon cancer patients and validation with spatial transcriptomics and large-scale histological analysis, we capture common transcriptional heterogeneity patterns between left- and right-sided malignant epithelia through delineating two side-specific expression meta-programs. The proliferation stemness meta-program is notably enriched in left-sided malignant epithelia that colocalize with Mph-PLTP cells, activated regulatory T cells (Tregs), and exhausted CD8-LAYN cells, constituting the glucose metabolism reprogramming niche. The immune secretory (IS) meta-program exhibits specific enrichment in right-sided malignant epithelia, especially in smoking patients with right-sided colon cancer. The IShigh malignant epithelia spatially localize in hypoxic regions and facilitate immune evasion through attenuating Mph-SPP1 cell antigen presentation and recruiting innate-like cytotoxicity-reduced CD8-CD161 cells.
What problem does this paper attempt to address?